Assessment and Retrospective: The First Two Remarkable Years of IMS

Take a look back at two remarkable years for the Institute of Medicine and Science (IMS), filled with scientific achievements, recognitions, and innovative initiatives.

2021: A Year of Launches and Recognitions

(March_2021:_Prestigious_Grant_for_Alexandre_Detappe_))

Alexandre Detappe was awarded the ERC Starting Grant 2020 to support his innovative project, “Theranolmmuno”, aimed at enhancing the therapeutic effectiveness of NK cells for cancer treatment through nanomedicine.

(April_15,_2021:_Launch_of_the_Medalis_Call_for_Projects))

IMS took a significant step forward by launching the first edition of the Medalis Call for Projects, dedicated to fostering therapeutic innovation.

(April_21,_2021:_First_Public_Scientific_Meeting))

IMS organized its first public scientific meeting via videoconference, allowing researchers and partners to discuss major scientific advancements.

(September_8,_2021:_A_Degree_for_Therapeutic_Innovation))

The University Diploma (DU) in Research and Therapeutic Innovation was created in partnership with ESBS. This interdisciplinary program aims to strengthen the skills of researchers and clinicians.

(October_25_and_November_18,_2021:_IMS’_Inaugural_Workshops))

Two inaugural workshops were held, focusing on major topics:

Technologies and Diagnostics in Pharmaceutical Production
New Approaches to Combat Glioblastoma Resistance

(November_25,_2021:_Two_Prestigious_Awards_for_Alain_Wagner))

Alain Wagner received two distinguished honors:

The Seqens Prize from the French Academy of Sciences
The Berthelot Medal

(December_3,_2021:_Alexandre_Detappe_Recognized))

Alexandre Detappe was awarded the Guy Ourisson Prize 2021, highlighting the excellence of his research in nanomedicine.

2022: Continued Progress and Scientific Recognition

(April_28,_2022:_Second_Public_Scientific_Meeting))

This time held in person, the second public scientific meeting focused on cancer treatment and inflammatory diseases.

(October_28_and_December_2,_2022:_Specialized_Workshops))

IMS organized the second edition of its annual workshops:

Toolkit for Therapeutic Innovation
Microfluidic Applications: From Research to Drug Discovery

(Through_the_year_))

The research teams at IMS have published no fewer than 26 scientific articles.

Conclusion

These two years reflect an exceptional dynamic at IMS. With prestigious funding, interdisciplinary training, scientific accolades, and groundbreaking innovations, the institute has established itself as a key player in biomedical research and therapeutic innovation.